Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
28.75    0.00 (0.00%)
Bid:
28.50
Ask:
29.00
Spread: 0.50 (1.754%)
Market Cap: £121.72m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Board Changes

26 May 2016 07:00

RNS Number : 3384Z
Mercia Technologies PLC
26 May 2016
 

FOR IMMEDIATE RELEASE

26 May 2016

 

Mercia Technologies PLC

"Mercia" or "the Group"

 

Board Changes

 

Mercia Technologies PLC (AIM: MERC), which is focused on the creation, funding and scaling of innovative technology businesses with high growth potential from the UK regions, announces that Ray Chamberlain, the Group's current Non-executive Chair has decided that having recently reached 70 years of age now is the appropriate time for him to step down from his role, whilst remaining a Non-executive Director. Susan Searle, currently Non-executive Deputy Chair of the Group, has been appointed as the new Non-executive Chair.

 

As a consequence of Susan's appointment, there are a number of changes to the composition of the Audit, Nominations and Remuneration Committees. Martin Lamb will become Chair of the Audit Committee, Susan Searle will become Chair of the Nominations Committee and Ian Metcalfe will remain Chair of the Remuneration Committee. All four Non-executive Directors will also now sit on all three committees.

 

Mark Payton, Chief Executive Officer of Mercia, commented:

 

"On behalf of the Board, I would like to thank Ray for his significant contribution to the creation and development of Mercia Technologies to date. As a successful and long standing technology investor he has played an instrumental role in the establishment and successful flotation of our Group and I am delighted that he will remain a key member of our Non-executive team.

 

Susan joined the Board of Mercia at the time of the Group's flotation in December 2014, bringing in-depth sector experience and expertise, having previously been the founder and Chief Executive Officer of Imperial Innovations Group plc. She has demonstrated a natural understanding of all aspects of Mercia's business model and her insights continue to prove invaluable as Mercia executes its growth strategy.

 

These changes provide strong continuity of leadership for the Board and I look forward to continuing to work with Susan as Chair and Ray as a Non-executive Director going forward."

 

 

For further information, please contact:

Mercia Technologies PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.merciatechnologies.com

 

+44 (0)330 223 1430

 

Cenkos Securities plc

Ivonne Cantu / Mark Connelly (NOMAD)

+44 (0)20 7397 8900

Buchanan

Sophie McNulty, Victoria Watkins, Stephanie Watson

www.buchanan.uk.com

+44 (0)20 7466 5000

 

About Mercia Technologies PLC

Mercia is a national investment group focused on the creation, funding and scaling of innovative businesses with high growth potential from the UK regions. Mercia benefits from 14 university partnerships and six offices across the Midlands, the North of England and Scotland, providing it with access to high quality, regional deal flow. Mercia is quoted on AIM with the epic "MERC".

 

Mercia's "complete capital solution" investment model initially nurtures businesses via its third party funds under management (expanded to circa £220 million following its acquisition of Enterprise Ventures Group) and then over time Mercia can provide further funding to its emerging stars thanks to its ability to deploy direct investment follow-on capital from its own balance sheet.

 

In a recent report (Source: Beauhurst, The Deal, 2015/16), Mercia was found to be the fifth most active investor in the UK and the fourth most active in technology. Since its IPO in December 2014, the Company has invested over £20 million directly across its portfolio of emerging stars and continues to seek both early stage third party investment opportunities as well as providing its emerging stars with the required capital and management support to build towards exits that will realise incremental value for Mercia shareholders.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAAKPDQOBKDPPB
Date   Source Headline
21st May 20197:00 amRNS£2.4million syndicated investment into Medherant
15th May 20197:00 amRNS£2.0million syndicated investment into Locate Bio
14th May 20197:06 amRNSConcepta PLC confirms first myLotus® pregnancies
2nd May 20197:00 amRNSNotice of Preliminary Results
11th Apr 20199:41 amRNSPDMR Dealing
10th Apr 20197:00 amRNSDirector/ PDMR Dealings
28th Mar 20197:00 amRNS£6.5m syndicated investment into Oxford Genetics
18th Mar 20194:23 pmRNSPDMR / Director Dealings
15th Mar 20191:19 pmRNSPDMR / Director Dealings
12th Mar 20197:06 amRNSPortfolio company Concepta secures partnership
28th Feb 20197:00 amRNSPortfolio company announces six licensing deals
20th Feb 20197:00 amRNSSoftware & the Internet Portfolio Update
5th Feb 20197:00 amRNSAppointment of NOMAD
3rd Dec 20187:00 amRNSHalf Year Results
31st Oct 20187:00 amRNSNotice of Results
29th Oct 20187:00 amRNSNew Direct Investment in W2 Global Data Solutions
18th Oct 20187:00 amRNSCapital Markets Day
16th Oct 20187:00 amRNSNew Emerging Star investment into Locate Bio
21st Sep 201810:47 amRNSResult of AGM
21st Sep 20187:00 amRNSAGM Statement
18th Sep 20187:00 amRNSAston EyeTech secures multi-million pound contract
13th Sep 20187:00 amRNSNotice of Capital Markets Day
29th Aug 20187:00 amRNSGrant of Options
16th Aug 20187:00 amRNSnDreams secures multi-million dollar contract
7th Aug 20187:00 amRNSOG wins significant multi-million pound contract
27th Jul 20189:30 amRNSPublication of Annual Report
17th Jul 20183:14 pmRNSPDMR / Director Dealings
2nd Jul 20187:00 amRNSPreliminary Results
20th Jun 20187:00 amRNSVirtTrade secures partnership with Formula 1
12th Jun 20187:00 amRNSBoard Appointment
21st May 20187:00 amRNSNotice of Preliminary Results
17th Apr 20187:00 amRNSBoard Change
26th Mar 20187:00 amRNSDeferred Consideration and Board Change
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.